Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

Prostate

Volumn 37, Issue 1, 1998, Pages 19-29

  Wikström, Pernilla ^a   Stattin, Pär ^a   Franck Lissbrant, Ingela ^a   Damber, Jan Erik ^a   Bergh, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Immunohistochemistry; Prostate cancer; Survival; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOSURVEILLANCE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TUMOR PROMOTION; TUMOR VASCULARIZATION;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 0031928528     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3     Document Type: Article

References (53)

1. Massagué J: The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
2. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
3. Yang EY, Moses HL: Transforming growth factor β1-induced changes in cell migration, probation, and angiogenes in the chicken chorioallantoic membrane. J Cell Biol 1990;111:731-741.
4. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA: A highly immunogenic tumor transfected with a murine transforming growth factor type 1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 1990;87:1486-1490.
5. Ilio KY, Sensibar JA, Lee C: Effect of TGF-β1, TGF-α and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture. J Androl 1995;16:482-490.
6. McKeehan WL, Adams PS: Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro Cell Dev Biol 1988;24:243-246.
7. Kyprianou N, Isaacs JT: Expression of transforming growth factor-β in the rat ventral prostate during castration induced programmed cell death. Mol Endocrinol 1989;3:1515-1522.
8. Martikainen P, Kyprianou N, Isaacs JT: Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology 1990;127:2963-2968.
9. Sutkowski DM, Fong C-J, Sensibar JA, Rademaker AW, Sherwood ER, Kozlowski JM, Lee C: Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture. Prostate 1992;21:133-143.
10. Steiner MS, Zhou Z-Z, Tonb DC, Barrack ER: Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 1994;135:2240-2247.
11. Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH: Transforming growth factor β1 as a biomarker for prostate cancer. J Cell Biochem 1992;16: 54-61.
12. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC: Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study. Hum Pathol 1993;24:4-9.
13. Tu H, Jacobs SC, Borkowski A, Kyprianou N: Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-β1 and bcl-2 expression. Int J Cancer 1996;69:357-363.
14. Steiner MS, Anthony CT, Metts J, Moses H: Prostate cancer cells lose their sensitivity to TGFβ1 growth inhibition with tumor progression. Urol Oncol 1995;1:252-262.
15. Morton DM, Barrack ER: Modulation of transforming growth factor β1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res 1995;55:2596-2602.
16. Contractor HE, Barrack ER, Breul J: Potential role of T-lymphocytes in prostate tumor growth enhancement by transforming growth factor beta1 (TGF β1). J Urol 1994;151:366.
17. Steiner MS, Barrack ER: Transforming growth factor-β1 over-production in prostate cancer: Effects of growth in vivo and in vitro. Mol Endocrinol 1992;6:15-25.
18. Massagué J, Cheifetz S, Boyd FT, Andres JL: TGF-β receptors and TGF-β binding proteoglycans: Recent progress in identifying their functional properties. Ann NY Acad Sci 1990;593:59-72.
19. Wikström P, Bergh A, Damber J-E: Expression of transforming growth factor-β receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment. Urol Res 1997;25:103-111.
20. Guo Y, Jacobs SC, Kyprianou N: Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer. Int J Cancer 1997;71:573-579.
21. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C: Loss of expression of transforming growth factor-β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 1996;2:1255-1261.
22. Williams RH, Stapleton AMF, Yang G, Truong LD, Rogers E, Timme TL, Wheeler TM, Scardino PT, Thompson TC: Reduced levels of transforming growth factor β receptor type II in human prostate cancer: An immunohistochemical study. Clin Cancer Res 1996;2:635-640.
23. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKW: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268: 1336-1338.
24. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB, Sporn MB: Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 1994;91:8772-8776.
25. Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang X-F, Brattain MG: Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 1994;269:26449-26455.
26. Franck-Lissbrant I, Stattin P, Damber J-E, Bergh A: Vascular density is a predictor of cancer specific survival in prostatic carcinoma. Prostate 1997;33:38-45.
27. Stattin P, Damber J-E, Karlberg L, Bergh A: Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer. J Urol 1997; 157:219-222.
28. Union Internationale Contre le Cancer (UICC): "TNM Classification of Prostate Tumours," 2nd ed. Berlin: Springer, 1978.
29. Mostofi FK, Sesterhenn IA, Sobin LH: "International Histological Classification of Prostate Tumours." Geneva: WHO, 1980.
30. Stattin P, Bergh A, Karlberg L, Tavelin B, Damber J-E: Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancer. Eur Urol 1997;32:404-409.
31. Taylor CR, Shi S-R, Chaiwun B, Young L, Imam SR, Cote RJ: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum Pathol 1994;25:263-270.
32. Flanders KC, Thompson NL, Cissel DS, Van Obberghen-Schilling E, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB: Transforming growth factor-β1: Histochemical localization with antibodies to different epitopes. J Cell Biol 1989; 108:653-659.
33. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, Miyazono K: Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 1993;75:681-692.
34. Panoskaltsis-Mortari A, Bucy RP: In situ hybridization with digoxigenin-labeled RNA probes: Facts and artifacts. Biotechniques 1995;18:300-307.
35. Derynck R, Rhee L, Chen EY, Van Tilburg A: Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Res 1987;15:3188-3189.
36. Kerr IF, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
37. Eastham JA, Truong LD, Rogers E, Kattan M, Flanders KC, Scardino PT, Thompson TC: Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest 1995;73:628-635.
38. Fráter-Schröder M, Muller G, Birchmeier W, Böhlen P: Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun 1986;137:295-302.
39. Baird A, Durkin T: Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun 1986;138:476-482.
40. Koochekpour S, Merzak A, Pilkington GJ: Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro. Cancer Lett 1996;102:209-215.
41. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-6274.
42. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
43. Gruber BL, Marchese MJ, Kew RR: Transforming growth factor-β 1 mediates mast cell chemotaxis. J Immunol 1994;152:5860-5867.
44. Fajardo LF, Prionas SD, Kwan HH, Kowalski J, Allison AC: Transforming growth factor β 1 induces angiogenesis in vivo with a threshold pattern. Lab Invest 1996;74:600-608.
45. Merzak A, McCrea S, Koocheckpour S, Pilkington GJ: Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor β 1. Br J Cancer 1994,70:199-203.
46. Welch DR, Farba A, Nakajima M: Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 1990;87:7678-7682.
47. Desruisseau S, Ghazarossian-Ragni E, Chinot O, Martin P-M: Divergent effect of TGFβ1 on growth and proteolytic modulation of human prostatic-cancer cell lines. Int J Cancer 1996;66: 796-801.
48. Sehgal I, Baley PA, Thompson TC: Transforming growth factor β1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res 1996;56:3359-3365.
49. Steiner MS: Peptide growth factors in prostate cancer: A focus on transforming growth factor-β1. AUA News 1996;1:5-10.
50. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Sensibar JA, Kim J-H, Kato M, Lee C: Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 1996;56:44-48.
51. Kim IY, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, Lee C: Loss of expression of transforming growth factor-β receptors is a poor prognostic indicator in prostate cancer patients. J Urol [Suppl] 1997;157:445.
52. Timme TL, Truong LD, Slawin KM, Kadmon D, Park SH, Thompson TC: Mesenchymal-epithelial interactions and transforming growth factor-β1 expression during normal and abnormal prostatic growth. Microsc Res Tech 1995;30:333-341.
53. Miniati DN, Chang Y, Shu W-P, Peehl DM, Liu BC-S: Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells. Cancer Lett 1996;104:137-144.